Ph.D. Biochemistry, University of Hull, UK.
B.Sc. Biological Sciences Class I Honours, University of East Anglia, UK.

Academic Background

Nuffield Department of Medicine, University of Oxford, UK. Initially Senior Molecular Biologist, appointed University Research Lecturer 1999, appointed Reader in Vaccinology 2004, appointed Jenner Investigator 2006, appointed Professor of Vaccinology 2010.
Research Scientist, Delta Biotechnology Ltd., Nottingham.
Research Scientist, Leicester Biocentre, Leicester University.

Research Interests

Novel influenza vaccines including a human challenge study demonstrating vaccine efficacy via T cell responses to conserved internal antigens of influenza
Viral-vectored vaccines that work by inducing strong and protective T and B cell responses

In January 2020 I initiated production of ChAdOx1 nCoV-19, and this vaccine is now approved for emergency use in 172 countries, with more than 350 million doses administered.


Over 200 publications, h index = 92, See Google Scholar